Genotype and allele frequency of a 32-base pair deletion mutation in the CCR5 gene in various ethnic groups: absence of mutation among Asians and Pacific Islanders
- PMID: 10575146
- DOI: 10.1016/s1201-9712(99)90022-x
Genotype and allele frequency of a 32-base pair deletion mutation in the CCR5 gene in various ethnic groups: absence of mutation among Asians and Pacific Islanders
Abstract
Background: A 32-base pair (bp) deletion mutation in the beta-chemokine receptor CCR5 gene has been associated with resistance against human immunodeficiency virus type 1 (HIV-1) infection and disease. Large-scale studies conducted among Caucasians indicate that individuals who are homozygous for this deletion mutation (D32/D32) are protected against HIV-1 infection despite multiple high-risk exposures, whereas CCR5/ D32 heterozygotes have a slower progression to acquired immunodeficiency syndrome (AIDS).
Objective: To determine the genotype and allele frequencies of the CCR5 gene 32-bp deletion mutation among ethnically diverse non-Caucasian populations.
Methods: DNA, extracted from blood collected between 1980 and 1997 from 1912 individuals belonging to various ethnic groups, including 363 Caucasians, 303 Puerto Rican Hispanics, 150 Africans, 606 Asians, and 490 Pacific Islanders, were analyzed for the CCR5 gene 32-bp deletion mutation by a polymerase chain reaction (PCR)-based assay, using an oligonucleotide primer pair designed to discriminate CCR5 alleles without restriction endonuclease analysis.
Results: The comparative frequency of CCR5/D32 heterozygosity was 61 of 363 (16. 8%) in Caucasians, 17 of 303 (5.6%) in Puerto Rican Hispanics, 9 of 490 (1.8%) in Pacific Islanders, 0 of 606 (0%) in Asians, and 0 of 150 (0%) in Africans.
Conclusions: The data confirm the high frequency of CCR5/D32 heterozygosity among Caucasians. Intermediate and low-level D32 allele frequencies among Puerto Rican Hispanics and Hawaiians could be attributed to recent European Caucasian gene flow. By contrast, the inability to detect the D32 allele among Asians and other Pacific Islander groups suggests that other mechanisms are responsible for resistance to HIV-1 infection in these populations.
Similar articles
-
CCR5 chemokine receptor genotype frequencies among Puerto Rican HIV-1-seropositive individuals.Bol Asoc Med P R. 1998 Jan-Mar;90(1-3):12-5. Bol Asoc Med P R. 1998. PMID: 9734151
-
Frequency of the CCR5 delta 32 mutant allele in HIV-1-positive patients, female sex workers, and a normal population in Taiwan.J Formos Med Assoc. 1997 Dec;96(12):979-84. J Formos Med Assoc. 1997. PMID: 9444918
-
Determination of the CCR5∆32 frequency in Emiratis and Tunisians and the screening of the CCR5 gene for novel alleles in Emiratis.Gene. 2013 Oct 15;529(1):113-8. doi: 10.1016/j.gene.2013.07.062. Epub 2013 Aug 9. Gene. 2013. PMID: 23933274
-
CCR5Δ32 in Brazil: Impacts of a European Genetic Variant on a Highly Admixed Population.Front Immunol. 2021 Dec 10;12:758358. doi: 10.3389/fimmu.2021.758358. eCollection 2021. Front Immunol. 2021. PMID: 34956188 Free PMC article. Review.
-
The CRISPR-Cas9 induced CCR5 Δ32 mutation as a potent gene therapy methodology for resistance to HIV-1 variant: a review.Eur Rev Med Pharmacol Sci. 2024 Mar;28(6):2430-2463. doi: 10.26355/eurrev_202403_35751. Eur Rev Med Pharmacol Sci. 2024. PMID: 38567606 Review.
Cited by
-
The CCR5 chemokine receptor mediates vasoconstriction and stimulates intimal hyperplasia in human vessels in vitro.Cardiovasc Res. 2014 Mar 1;101(3):513-21. doi: 10.1093/cvr/cvt333. Epub 2013 Dec 9. Cardiovasc Res. 2014. PMID: 24323316 Free PMC article.
-
C-C chemokine receptor 2 and C-C chemokine receptor 5 genotypes in patients treated for chronic hepatitis C virus infection.Immunol Res. 2002;26(1-3):167-75. doi: 10.1385/IR:26:1-3:167. Immunol Res. 2002. PMID: 12403355
-
Chemokine (CCR) and fractalkine (CX3CR) receptors and end stage renal disease.Inflamm Res. 2011 Apr;60(4):399-407. doi: 10.1007/s00011-010-0284-3. Epub 2010 Dec 4. Inflamm Res. 2011. PMID: 21132346
-
Association analysis and allelic distribution of deletion in CC chemokine receptor 5 gene (CCR5Δ32) among breast cancer patients of Pakistan.Mol Biol Rep. 2019 Apr;46(2):2387-2394. doi: 10.1007/s11033-019-04699-6. Epub 2019 Mar 8. Mol Biol Rep. 2019. PMID: 30848448
-
Association study of CCR5 delta 32 polymorphism among the HLA-DRB1 Caucasian population in Northern Paraná, Brazil.J Clin Lab Anal. 2008;22(4):229-33. doi: 10.1002/jcla.20225. J Clin Lab Anal. 2008. PMID: 18623133 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical